D-1104-2018 Class III Terminated

Recalled by Jubilant Cadista Pharmaceuticals, Inc. — Salisbury, MD

FDA drug recall D-1104-2018 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Aug 14, 2018 and is designated Class III. Reason for recall: Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing. The recall status is terminated (terminated Jan 8, 2020). Affected quantity: 9,552 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 29, 2018
Initiation Date
Aug 14, 2018
Termination Date
Jan 8, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9,552 bottles

Product description

Valsartan Tablets USP, 80 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-361-90

Reason for recall

Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.

Distribution pattern

Product was distributed throughout the United States to wholesalers and retailers.

Code information

Lot #: VR217013A, Exp. 08/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1104-2018
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1104-2018. Report a data issue: hello@regdatalab.com.